Published in J Oncol on February 09, 2014
Cancer and Venous Thromboembolic Disease: A Review. Oncologist (2017) 0.78
Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer. Geburtshilfe Frauenheilkd (2016) 0.75
Implantable port thrombosis in cancer patients: a monocentric experience. Cancer Biol Med (2016) 0.75
Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis. Cent Eur J Immunol (2015) 0.75
Performance of venous port catheter insertion by a general surgeon: a prospective study. Int Surg (2015) 0.75
Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol (2005) 2.53
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet (2009) 2.37
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med (1990) 2.32
Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol (2009) 2.22
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol (2005) 2.14
Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol (2006) 1.67
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol (2011) 1.54
Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thromb Haemost (2004) 1.49
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol (2005) 1.29
The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res (2005) 1.27
Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost (2005) 1.23
Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost (1996) 1.17
Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J (2002) 1.14
Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre. Eur J Surg Oncol (2011) 1.10
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'. Ann Oncol (2011) 1.00
Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy. J Thromb Haemost (2008) 0.96
Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae. Eur J Intern Med (2007) 0.87
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica (2003) 0.87
Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev (2011) 0.85
Peripherally inserted central catheter in leukemia: insertion site determines clotting risk. Leuk Lymphoma (2010) 0.78